(STMN) Straumann Holding - Ratings and Ratios

Straumann Holding AG is a global leader in dental restoration and orthodontic solutions, specializing in the development, manufacturing, and distribution of advanced dental implants, prosthetics, and orthodontic aligners. The company’s product portfolio includes titanium and ceramic implants, CADCAM prosthetics, clear polymer aligners, and biomaterials for tissue regeneration. It also provides restorative solutions such as abutments and milling components, as well as digital equipment like scanners, milling machines, and 3D printers. Straumann’s offerings are complemented by software licenses and training programs. The company serves general dentists, specialists, and dental laboratories through a global network of subsidiaries, partners, and third-party distributors. Founded in 1954 and headquartered in Basel, Switzerland, Straumann has established itself as a pioneer in the dental restoration industry, consistently innovating to address tooth replacement, correction, and restoration needs.

Straumann Holding AG (SW:STMN) operates in the Health Care Equipment sector. The stock has a market capitalization of 15479.50M CHF, with a trailing P/E of 33.83 and a forward P/E of 26.53. The price-to-book ratio stands at 7.59, and the price-to-sales ratio is 6.18. The company demonstrates strong profitability, with a return on equity (RoE) of 28.68. As of the latest data, the stock is trading at 97.12 CHF, with a 20-day average volume of 557,023 shares. The stock’s short-term trend indicators show a decline, with the SMA 20 at 100.35, SMA 50 at 112.24, and SMA 200 at 117.72. The average true range (ATR) is 4.12, indicating moderate volatility.